Wall Street analyst estimates for SANUWAVE Health Inc. (SNWV): consensus price target, buy/hold/sell recommendations and forecasts for revenue, EPS and EBITDA for the upcoming fiscal years.
SANUWAVE Health, Inc. is a shockwave technology company, which engages in the development and commercialization of patented noninvasive, biological response activating devices. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration.
Analyst Consensus
| Strong Buy | 0 |
| Buy | 2 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 2 |
| Avg rating (1-5) | 1.00 |
Recent Earnings Surprises
| Date | EPS Actual | EPS Est. | vs Est. |
|---|---|---|---|
| 2026-11-06 | $0.01 | ||
| 2026-08-06 | $-0.08 | $-0.03 | -166.7% |
| 2026-05-12 | $-0.17 | $-0.14 | -21.4% |
| 2026-03-26 | $0.03 | $0.17 | -82.4% |
| 2025-11-07 | $0.46 | $0.32 | +43.8% |
| 2025-08-08 | $0.01 | $-0.09 | +111.1% |
| 2025-05-09 | $-0.66 | ||
| 2025-03-20 | $-1.21 |
Valuation Ratios
| P/E Ratio | 2.47 |
| Price / Book | 12.75 |
| EV / EBITDA | 2.42 |
| Dividend Yield | 0.00% |
Income Statement (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.4M | $738527 | $1.9M | $1.0M | $4.1M | $13.0M | $16.7M | $20.4M | $32.6M | $44.1M |
| Cost of Revenue | $565129 | $241970 | $693664 | $538923 | $1.2M | $5.0M | $4.3M | $6.0M | $8.1M | $10.1M |
| Gross Profit | $810934 | $496557 | $1.2M | $489807 | $2.9M | $8.0M | $12.4M | $14.4M | $24.6M | $34.0M |
| Research & Development | $1.1M | $1.3M | $1.7M | $1.2M | $1.2M | $1.1M | $567000 | $579000 | $673000 | $1.4M |
| Selling, General & Admin | $2.7M | $3.0M | $7.3M | $8.0M | $18.9M | $20.3M | $20.0M | $13.6M | $17.7M | $26.8M |
| Operating Expenses | $4.1M | $4.3M | $8.3M | $9.3M | $28.1M | $22.2M | $21.4M | $14.9M | $19.1M | $29.0M |
| Operating Income | -$3.3M | -$3.8M | -$7.2M | -$8.8M | -$25.2M | -$14.1M | -$9.0M | -$540000 | $5.4M | $4.9M |
| EBITDA | -$3.0M | -$4.4M | -$7.1M | -$8.5M | -$27.4M | -$18.9M | $4.8M | -$9.2M | -$16.6M | $19.4M |
| Interest Expense | $854980 | $1.1M | $4.5M | $1.8M | $2.5M | $7.1M | $14.1M | $15.6M | $13.6M | $6.2M |
| Pre-tax Income | -$6.4M | -$5.5M | -$11.6M | -$10.4M | -$30.9M | -$27.2M | -$10.3M | -$25.8M | -$31.3M | $11.9M |
| Income Tax | $3.1M | 0 | $45012 | 0 | 0 | $28000 | $2000 | $4000 | $27000 | $86000 |
| Net Income | -$6.4M | -$5.5M | -$11.6M | -$10.4M | -$30.9M | -$27.3M | -$10.3M | -$25.8M | -$31.4M | $11.8M |
| EPS | $-22.50 | $-15.00 | $-29.17 | $-19.26 | $-30.68 | $-19.72 | $-7.02 | $-12.19 | $-7.03 | $1.38 |
| EPS (Diluted) | $-22.50 | $-15.00 | $-29.17 | $-19.26 | $-30.68 | $-19.72 | $-7.02 | $-12.19 | $-7.03 | $0.41 |
| Shares Outstanding (Diluted) | $286986 | $370236 | $398767 | $541442 | $1.0M | $1.4M | $1.5M | $2.1M | $4.5M | $9.1M |
Price
| Price | $4.46 |
| Market Cap | $38M |
| Exchange | NASDAQ |
| Country | US |
Related companies: FHTX · HSDT · IMRX · INGN · MASS · NNOX · OM
Explore sector: Healthcare · Medical - Devices
More sections of SNWV: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks